Quantum computing stocks were all the rage at the end of 2024, but just one week into January they're taking a turn.
Quantum computing stocks plunged on Tuesday following comments from Nvidia Corp (NASDAQ:NVDA, ETR:NVD) CEO Jensen Huang who suggested the technology is still decades away. During an investor conference, Huang suggested that quantum computing may still be 15 to 30 years away from being “very useful”, dampening investor enthusiasm across the sector.
Quantum computing stocks saw huge interest from investors and Benzinga readers in 2024, with several ranking among the most-searched tickers on Benzinga Pro in 2024.
Companies like Rigetti Computing (RGTI), IONQ Inc. (IONQ) and Quantum Computing (QUBT) sunk as much as 30% in the premarket. The selling action comes from Nvidia (NVDA) CEO Jensen Huang saying the tech could be 15 to 30 years away.
Shares of Rigetti Computing, Quantum Computing, IonQ and D-Wave were down sharply after Nvidia's Jensen Huang said that “very simple quantum computers” could be 20 years away.
U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% on Wednesday.
Quantum computing stocks sank on Wednesday, pausing a year-long rally, after Nvidia CEO Jensen Huang said the technology's practical use was likely two decades away.
Quantum computing stocks dropped Wednesday after Nvidia CEO Jensen Huang declared that useful quantum computers are likely decades in the future.
Quantum computing stocks dived after Nvidia CEO Jensen Huang said Tuesday night that the tech won't be "very useful" for 15-30 years. The post Quantum Computing Stocks Dive After Nvidia CEO Says Tech 15-30 Years Away appeared first on Investor's Business Daily.
Quantum computing has emerged as a strong investment theme over the past several months, with the trend fully expected to continue throughout the fresh year. And these 2 stocks provide great exposure.
Quantum-Si Inc. QSI is stealing the biotech spotlight with a jaw-dropping 327% surge over the past six months. The proteomics pioneer's stock now sits at $4.10, boasting a strong bullish trend and catching investors' attention.
Trading to become available January 14th under 'QNTM' TORONTO, ONTARIO / ACCESSWIRE / January 7, 2025 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), today announced its approval to dual list its shares on Upstream, a MERJ Exchange market and global securities trading app.